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Summary: A simple and effective technique of long-term storage of human low density lipoproteins (LDL) has
been developed. The technique involves the addition of 1.4 mol/1 (or 10% by volume) dimethyl sulphoxide directly
to a solution of the freshly isolated LDL in high salt buffer, and subsequent freezing and storage for up to 2 years
at —70 °C. We have shown that freshly isolated LDL, "preserved" as described above, are able to keep their native
properties for a long period, i. e.:
a) electrophoretic behaviour in non-denaturing (or with sodium dodecyl sulphate, 1 g/1) polyacrylamide 2—16%
gradient gel electrophoresis;
b) immunoreactivity of apolipoprotein B (analyzed by radial immunodiffusion, electroimmunoassay and immuno-
turbidimetric assay);
c) immunogeneity of apolipoprotein B;
d) an average size of LDL particles (analyzed by electron microscopy);
e) ability to bind with Β,Ε-receptors of human skin fibroblasts.
The technique can also be applied to radiolabelled LDL samples. Taking into consideration the labour- and time-
consuming procedure of obtaining and characterizing LDL, and the preferred use of single well-characterized LDL
preparation, we recommend that the above technique of LDL long-term storage be applied in various clinical and
biomedical studies.
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exist widely known techniques of human and animal
cells long-term storage by freezing them in the presence
of liquid cryoprotectors (dimethyl sulphoxide, glycerol
and etc.) and keeping them at -70 °C or, preferably, in
liquid nitrogen (13-14).
In this work we suggest a simple and effective technique
of long-term LDL storage at -70 °C by freezing them
in the presence of 1.4 rnol/1 (10% by volume) dimethyl
sulphoxide. It is shown that this storage method does
not cause the loss of the native properties of LDL by
using them as an immunogen for obtaining the poly-
clonal monospecific sheep's antiserum, as a primary
standard for apolipoprotein B measurements by immu-
nochemical assays and as a ligand. The data reported
here have been obtained as a result of two-year experi-
ments.
Materials and Methods
Reagents
Phenyl methylsulphonyl fluoride, sodium bromide, and dimethyl
sulphoxide were obtained from Merck (Darmstadt, Germany). Car-
rier-free Na125I was obtained from Amersham (Arlington Heigts,
IL). Reagents for polyacrylamide gel electrophoresis were from
Serva (Heidelberg, Germany). Horseradish peroxidase (EC
1.11.1.7) and peroxidase substrate (3,3'-diaminobenzidine) were
obtained from Sigma Chemical Company (St. Louis, MO).
The candidate international standard plasma pool for apolipopro-
tein quantitation No. 1883 was obtained from the Centers for Dis-
ease Control (Atlanta, Georgia). A reference serum (Lot No.
063511) with assigned values for apolipoprotein A-I (1.62 g/1) and
apolipoprotein B (1.21 g/l) was obtained from Behringwerke AG
(Marburg, Germany).
Collection of specimens
Blood was collected from hyperlipidaemic and normolipidaemic
individuals by venipucture into Vacutainer tubes (Becton-Dickin-
son, Rutherford, N J) in the absence of ethylenediamine-tetraace-
tate, following a 12-14 h fast, and pooled. Upon separation at 4 °C
by low-speed centrifugation, the serum was prepared for the imme-
diate isolation of low density lipoprotein fraction. Disodium ethyl-
enediamine-tetraacetate, sodium azide, and phenyl methylsulpho-
nyl fluoride were added to final concentration of 1 mmol/1, 0.2 g/1,
and 1 mmol/1, respectively.
Isolation and characterization of LDL
LDL (d 1.030-1.050 kg/1) was isolated from pooled serum of in-
dividuals by sequential ultracentrifugation as previously described
(15) in a L8-70 ultracentrifuge (Beckman Instruments, Paolo Alto,
U.S.A.) using 45Ti rotor with potassium bromide being substi-
tuted for sodium bromide. Immediately after recentrifugation at
d 1.050 kg/1, the LDL fraction was filtered through a filter stack
of glassfibre prefilter and 0.2 micron filter (Sartorius GmbH, Goet-
tingen, Germany) under sterile conditions. LDL purity was as-
sessed by 1 g/1 sodium dodecyl sulfate, 2-16% gradient polyacryl-
amide gel electrophoresis (16) and by Ouchlerlony^ method (17)
with Calbiochem Corp. (San Diego, CA) anti-apolipoprotein A-I,
anti-apolipoprotein A-II and anti-apolipoprotein E antibodies, and
with home-made anti-apolipoprotein B antibodies.
Total LDL protein concentration was determined by the method of
Lowry et al. (18) as modified by Albers et al. (19). A standard
curve was prepared by diluting the bovine plasma albumin standard
II (1.37 g/1, Lot No. 34522, Bio-Rad Laboratories, Richmond, CA)
to 0.046, 0.091, 0.137, and 0.228 g/1 in 0.15 mol/1 sodium chloride.
Samples were diluted with 0.15 mol/1 sodium chloride to three
different concentrations within the working range.
Total cholesterol, unesterified cholesterol and triacylglycerols were
measured by enzymatic methods using Boehringer (Mannheim,
Germany) reagents. Phospholipids were determined as phosphorus
(20) using an average relative molecular mass of Afr = 775 for
phospholipid.
LDL used in receptor-binding studies was radiolabelled with I?5I
using the iodine monochloride procedure of McFarlane (21) as
modified by Bilheimer et al. (22). The specific radioactivity of the
apolipoprotein B^lOO was about 400 counts/min · ng of protein,
and over 97% of the radioactivity was precipitable by incubation
with 100 g/1 trichloroacetic acid solution at 4 °C.
Lipoprotein-deficient serum was obtained by double ultracentrifu-
gation of the freshly pooled serum of healthy donors with a density
of 1.25 kg/1 for 48 h at 105000g. After centrifugation, the serum
was dialyzed against 0.15 mol/1 sodium chloride, sterilized by
filtration (Sartorius filters, 0.2 μηι), frozen, and stored at -40 °C.
The concentration of apolipoprotein B-containing lipoproteins in
the lipoprotein-deficient serum did not exceed 0.1 mg/1.
Preparation of antiserum and antibody-enzyme
conjugate _*_
Isolated LDL was used to prepare anti-apolipoprotein Β antiserum
by immunization in sheeps as previously described (23). The speci-
fity of the antisera obtained was assessed by double radial immuno-
difrusion and two-dimensional immunoelectrophoresis with home^
made apolipoprotein A-I, apolipoprotein A-II, apolipoprotein E,
apolipoprotein Cs, apolipoprotein E, apolipoprotein(a), and with
lipoprotein-deficient serum. The IgG fraction for Western blotting
was obtained by precipitation with saturated ammonium sulphate
as described (24). Rabbit anti-sheep IgG antibodies were conju-
gated with horseradish peroxidase as previously described (24).
Cryopreservation and storage of LDL
Each LDL preparation was divided into 16—18 portions (0.3 ml).
33 μΐ of dimethyl sulphoxide per 0.3 ml (10% by volume) was
added to the first 12—14 portions and 33 μΐ of sodium chloride/
sodium bromide solution with the density 1.05 kg/1 per 0.3 ml
(10% by volume) was added to the remaining four portions which
were used as controls. Both dimethyl sulphoxide and sodium chlo-
ride/sodium bromide solution with the density 1.05 kg/1 were pre-
viously filtered through a filter stack of glassfibre prefilter and 0.2
micron filter (Sartorius GmbH, G ttingen, Germany) under sterile
conditions. Two from four control portions were stored at 4 °C.
Two other control portions and the portions of the LDL with di-
methyl sulphoxide were placed into a foam plastic container with
a wall thickness of 2 cm and slowly freezed (about l.°C per min)
in the ultra low freezer (Sanyo, Japan) at -70 °C as recommended
for preservation of human or animal cells (13, 14). Immediately
before the use, the LDL portions were quickly defrosted at 37 °C.
Polyacrylamide gradient gel electrophoresis
The apolipoprotein B fragmentation was studied on home-made
slab 2-16% polyacrylamide linear gradient gels containing 1 g/1
sodium dodecyl sulphate (16). The samples were heated'for 5 min
at 100 °C in 50 mmol/1 Tris, pH 6.8, 30 g/1 sodium dodecyl sul-
phate, 200 g/1 glycerol, 50 g/1 2-mercaptoethanol. The eleetropho-
resis was carried out at 20 mA for 20 h. The proteins were either
stained with Coomassie Blue R-250 or transferred to nitrocellulose
paper (see below). » f
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Non-denaturing gradient polyacrylamide gel electrophoresis of
LDL was done on Pharmacia Electrophoresis Apparatus (GE 2/4)
using home-made slab 2—16% polyacrylamide linear gradient gels
in 14 mmol/1 Tris, 110 mmol/1 glycine, 0.1 g/1 sodium azide, pH
8.3, as described by Krauss & Burke (25). The gels were prerun
30 min at 50 V. Routinely, the samples containing 15 μg of protein
were applied to each sample well. Electrophoresis was started at
30 V for l h and continued for 20 h at 80 V. Gels were stained
with Coomassie Blue R-250 for protein. In some cases LDL sam-
ples were prestained with acetylated Sudan Black B. Unstained
gels were used for immunoblotting techniques.
Immunoblo t t ing
After electrophoresis, the LDL particles were blotted (26) to nitro-
cellulose paper (0.45 μηι, Serva, Heidelberg, Germany) by the
electrophoretic transfer of the gel in the electrophoretic buffer at
100 mA for up to 72 h at 4 °G. All additional operations were
performed as described (27).
Immunochemica l assays
Single radial immunodiffusion was performed with commercially
available M-Partigen-Apolipoprotein B plates from Behringwerke
AG (Marburg, Germany) according to the manufacturer's instruc-
tions for maximal diffusion time of 96 h at 37 °C. Electroimmu-
noassay was performed by the method ofLaurell (28) using 10 g/1
agarose (Sigma Chemical Company, St. Louis, MO), containing 15
g/1 antiserum to human apolipoprotein B. The LDL samples were
diluted to three different concentrations within the working range.
All subsequent operations were performed as described (29). Apoli-
poprotein B values in the LDL samples were also determined by
the immunoturbidimetric assay as described (30) with some modi-
fications. Briefly, the LDL samples were diluted to three different
concentrations with phosphate-buffered saline (per litre: 9 g of so-
dium chloride, 10 mmol of monopotassium phosphate, pH 7.4)
within the working range (0.3—2.5 g/1). Antiserum was diluted 10-
fold in phosphate-buffered saline containing 40 g of polyethylene
glycol 6000 (Serva, Heidelberg, Germany) per litre and preincu-
bated for 30 min at 20-25 °C. Then, 25 μΐ of diluted LDL was
added to 750 μΐ of diluted antiserum. Samples were vortexed, incu-
bated at 20—25 °C for 60 min, vortexed again and the changes in
turbidity of the samples against a reagent blank (mixture of 25 μΐ
of sample diluent and 750 μΐ of diluted antiserum) were measured
at 340 nm using a Spectronic 2000 spectrophotometer (Bausch &
Lomb, Rochester, New York). A standard curve generated by least-
squares linear regression analysis was used to calculate the concen-
trations of the unknowns.
Standards, quality controls and samples were analyzed in triplicate
in all immunochemical, protein, and lipid assays.
Cells
Human skin fibroblasts (6th—10th passages) were grown from
forearm skin biopsies of healthy donors. The cells were cultured at
37 °C in an atmosphere of 5% CO2/95% air in plastic flasks with
Eagles's minimum essential medium containing 25 mmol/1 Hepes,
220 mmol/1 sodium bicarbonate, 10 g/1 non-essential amino acids,
100 mg/1 canamycin, 2 mmol/1 glutamine, and 150 g/1 fetal calf
serum (medium A). The cells were then plated onto 60-mm Petri
dishes at a cell density of 1 X 105 cells per dish. Three or four
days later, the cells were washed with phosphate-buffered saline
and the medium of the same composition as medium A but contain-
ing 100 g/1 lipoprotein-deficient serum instead of fetal calf serum
(medium B) was added and cells were incubated for 48 h.
Measurements of LDL binding, internalization and
degradation
The amount of surface-bound 12SI-labelled LDL, and intracellular
I25l-labelled LDL was measured in intact fibroblast monolayers
essentially as described by Goldstein, Basu & Brown (8). Typically,
after incubating the cells at 37 °C for 3 h in the presence of various
amounts of I25l-labelled LDL (5, 10 or 20 mg/1 of [125I]LDL pro-
tein) for the specific binding, and I25l-labelled LDL and a 20-fold
excess of unlabelled LDL for the non-specific binding, cell mono-
layers were washed at 4 °C 5 times with phosphate-buffered saline
containing 2 g/1 bovine serum albumin and twice with buffer with-
out bovine serum albumin. The cells were then incubated for l h
with 2ml of the medium B, containing dextran sulphate (10 g/1),
at 4 °C with shaking. The amount of LDL bound was determined
from the dextran sulphate-releasable radioactivity in the medium.
The cells were then washed and dissolved in 100 mmol/1 sodium
hydroxide for determination of LDL internalization and protein
content. LDL degradation was determined as the difference be-
tween the amount of non-iodine, non-lipid trichloroacetic acid-sol-
uble radioactivity in the medium and the amount due to spontane-
ous degradation. The latter was measured in duplicate incubations
with no cells present in the system.
Electron microscopy
Samples of LDL were negatively stained with 20 g/1 sodium phos-
photungstate (pH 7.4) and immediately examined in the electron
microscope as previously described (31).
Results
Electrophoretic invest igat ions
The data of non-denaturing 2—16% gradient polyacryl-
amide gel electrophoresis show that by the storage of
freshly isolated LDL ("fresh" LDL) within 40-60 days
at 4 °C particles were formed, having less electrophoret-
ical mobility, well stained by Sudan Black, Coomassie
Blue R-250 and interacting with sheep anti-human apo-
lipoprotein B antibodies by immunostaining (see fig. 1,
A—C, lane 2). The samples of the same LDL, containing
1.4 mol/1 dimethyl sulphoxide and freezed as described
in Materials and Methods ("preserved" LDL) after 2
years of storage at —70 °C did not contain such particles
(see fig. 1, A—C, lane 3) and had an electrophoretical
pattern similar to freshly isolated LDL (see fig. 1, A—C,
lane 1). The freezing and subsequent storage at —70 °C
within 2 years of the same LDL not containing dimethyl
sulphoxide ("control" LDL) led to the formation of par-
ticles migrating significantly slower than LDL (see fig.
1, A—C, lane 4) and having similar abilities to be
stained by Sudan Black, Coomassie Blue R-250 and in-
teract with sheep anti-human apolipoprotein B antibod-
ies as compared with particles formed under long-term
storage of LDL at 4 °C. It is obvious that the particles
formed in both cases are aggregated LDL.
To examine probable apolipoprotein B fragmentation we
have analyzed the samples of freshly isolated LDL,
"fresh", "preserved" and "control" LDL (the latter two
- after two-year storage at -70 °C) by 2-16% gradient
polyacrylamide gel electrophoresis in the presence of
1 g/1 sodium dodecyl sulphate with the subsequent im-
munoblottings as described in Materials and Methods.
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Fig. 1 Non-denaturing 2-16% gradient polyacrylamide gel elec-
trophoresis of: freshly isolated LDL (A-C, line 1), "fresh" LDL
- stored for 2 months at 4 °C (A-C, lane 2), "preserved" LDL
- frozen in the presence of 1.4 mol/1 dimethyl sulphoxide and
subsequently stored for 2 years at -70 °C (A-C, lane 3), "control"
LDL - frozen without dimethyl sulphoxide and subsequently
stored for 2 years at -70 °C (A-C, lane 4). Twenty μg of LDL
3 4
were electrophoresed in all cases. Gels stained for lipoprotein with
Sudan Black (A), for protein with Coomassie Blue R-250 (B) or
LDL samples were immunodetected on a blot of gel by the sheep
polyclonal anti-human-apolipoprotein B immunoglobulins and
then by horseradish peroxidase-conjugated rabbit anti^sheep IgG
antibodies added followed by colour development (C).
The data obtained show no significant differences be-
tween the analyzed samples and no apolipoprotein Β
fragmentation (data not shown).
Similar results were obtained for three different LDL
preparations. Hence the given data prove that the freez-
ing of freshly isolated native LDL in the presence of 1.4
mol/1 dimethyl sulphoxide and their subsequent storage
at —70 °C for two-year period did not cause any signifi-
cant changes in electrophoretic pattern.
In addition, it has been demonstrated by non-denaturing
2-16% gradient polyacrylamide gel electrophoresis that
freezing and subsequent thawing of the "preserved"
LDL according to the procedure described in Materials
and Methods did not cause changes in electrophoretic
pattern even after three-fold repetition. In contrast, the
freeze-thawing of "control" LDL (not containing di-
methyl sulphoxide) led to the formation of aggregated
LDL, whereas the aggregation degree was highly depen-
dent on the number of freeze-thawing cycles. The gels
were stained by Sudan Black; similar results were ob-
tained by staining by Coomassie Blue R-250 (data not
shown). Thus, the given data indicate a certain antiag-
gregatory effect of dimethyl sulphoxide on LDL even
after three-fold repetition of freeze-thawing procedure.
To study the effect of freezing and subsequent storage
in the presence of dimethyl sulphoxide upon the electro-
phoretic pattern of radiolabelled LDL, the fresh LDL
sample was radiolabelled with 125I as described in Mate-
rials and Methods. One portion was subsequently frozen
in the presence of 1.4 mol/1 dimethyl sulphoxide and
stored at -70 °C within 7 days ("preserved" [I25I]LDL),
whereas another one was stored at 4 °C ("freshly iso-
lated" [I25I]LDL). Equal aliquots of both "freshly iso-
lated" and "preserved" [125I]LDL were analyzed by non-
denaturing 2-16% gradient polyacrylamide gel electro-
phoresis as described in Materials and Methods. After
electrophoresis, the LDL particles were stained by Coo-
massie R-250 or transferred to nitrocellulose paper as
described in Materials and Methods. After drying, auto-
radiography was performed at 4 °C using an intensifying
screen for 10 min. No differences were found in the
electrophoretic patterns for both "freshly isolated"^ and
"preserved" [125I]LDL samples.
Lipid and protein composition
To study the impact of freezing and subsequent storage
in the presence of dimethyl sulphoxide upon the LDL
lipid and protein content, we compared the results (for
three various LDL preparations — LDL1, LDL2, LDL3)
of the total and free cholesterol, phospholipid, triacyl-
glycerol and protein determinations, obtained immedi-
ately after LDL isolation ("freshly isolated" LDL), and
after freezing with 1.4 mol/1 dimethyl sulphoxide as de-
scribed in Materials and Methods, and subsequent stor-
age for 2 years at -70 °C ("preserved" LDL). Table 1
shows that there is no significant difference between the
three cases.
Thus, freezing LDL in the presence of dimethyl sulph-
oxide and subsequent long-term storage at -70 °C have
no effect on the results of the LDL lipid and protein
determinations.
Immunogeneity of LDL
The LDL samples frozen in the presence of dimethyl
sulphoxide ("preserved" LDL) after various periods
(from 1 month up to 2 years) of storage at -70 °C were
used as an antigen to obtain polyclonal sheep antisera
against apolipoprotein B. The analysis of specificity by
double radial immunodiffusion and two-dimension im*
munoelectrophoresis shows that there is no difference
between the above antisera and the one obtained by
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Tab. 1 Effect of LDL freezing with 1.4 mol/1 dimethyl sulphoxide and subsequent storage at
—70 °C on lipid and protein quantitation0.
Analyte Concentration of analyte, g/1
·-
Total cholesterol
Free cholesterol
Triacyglycerols
Phospholipid
Protein
LDL1
freshly
isolated
38.3 ± 0.4
10.8 ± 0.3
6.1 ±0.2
22.3 ± 0.6
23.5 ± 0.7
preserved
38.1 ± 0.8
10.9± 0.3
6.2 ± 0.2
22.6 ± 0.7
23.7 ± 0.5
LDL2
freshly
isolated
22.6 ± 0.5
6.3 ± 0.3
3.9 ± 0.1
14.6 ± 0.5
13.4 ±0.4
preserved
22.8 ± 0.4
6.4 ± 0.3
3.8 ± 0.1
14.4 ± 0.4
13.6 ±0.4
LDL3
freshly
isolated
34.8 ± 0.4
10.7 ± 0.4
5.9 ± 0.2
23.8 ± 0.6
22.0 ± 0.5
preserved
35.0 ± 0.5
10.8 ± 0.4
6.0 ± 0.2
23.6 ± 0.6
22.1 ± 0.5
Tliree LDL preparations (LDL1, LDL2 and LDL3) were obtained
as described in Materials and Methods. Aliquots of LDL were
assessed for lipid and protein content immediately after isolation
("freshly isolated") and after freezing and subsequent
storage in the presence of 1.4 mol/1 dimethyl sulphoxide for 2 years
at -70 °C ("preserved"). All values are means ± SD from tripli-
cate determinations.
freshly isolated LDL. The titre determination by an im-
munoturbidimetric assay (approximately 0.5 g/1) also
showed no significant differences between the antisera.
We later successfully used the antisera obtained with
"preserved" LDL in kits for immunoturbidimetric apoli-
poprotein B determination in human sera by mass
screening.
Hence the LDL freezing in the presence of dimethyl
sulphoxide and subsequent long-term storage at —70 °C
do not exert significant effects upon LDL immuno-
genic properties.
Apolipoprotein B immunoreact ivi ty
To study the influence of the freezing and storage pro-
cedures upon the apolipoprotein B immunoreactivity, we
have performed apolipoprotein B analysis of two dif-
ferent LDL preparations (LDL1 and LDL2) by three im-
munoprecipitin methods: single radial immunodiffusion,
electroimmunoassay and immunoturbidimetric assay.
LDL samples were analyzed immediately after isolation
("freshly isolated" LDL), after freezing and storage for
up to 2 years at — 70 °C both in the presence of 1.4
mol/1 dimethyl sulphoxide ("preserved" LDL) and in the
absence of dimethyl sulphoxide ("control" LDL). As
shown in table 2 the results of the apolipoprotein B de-
termination by three analytical methods in "freshly iso-
lated" LDL and in "preserved" LDL did not differ sig-
nificantly (at p > 0.01) between both LDL preparations
(LDL1 and LDL2). In contrast, the apolipoprotein B val-
ues in "control" LDL determined by "gel" techniques
(single radial immunodiffusion and electroimmunoas-
say) significantly differ (at p < 0.01) from the ones for
"freshly isolated" and "preserved" LDL. Depending
upon the method (single radial immunodiffusion or
electroimmunoassay) the difference ranged from 16—
23%. A similar difference was not observed for immu-
noturbidimetric assay (see tab. 2).
Thus, freezing with 1.4 mol/1 dimethyl sulphoxide and
subsequent storage of LDL for up to 2 years at —70 °C
do not effect the apolipoprotein B immunoreactivity, at
least in the three immunoassays used.
Cell studies
To study the effect of LDL freezing with 1.4 mol/1
dimethyl sulphoxide and subsequent storage upon the
LDL-receptor activity, equal aliquots of "freshly iso-
lated" and "preserved" [I25I]LDL were used in the
experiments to measure the specific binding, internal-
ization and degradation of LDL by fibroblasts as de-
scribed in Materials and Methods. As shown in table
3 the values of specific binding, internalization and
degradation of LDL by fibroblasts did not significantly
(at p > 0.01) differ for "freshly isolated" and "pre-
served" [125I]LDL, thus indicating the absence of a
considerable effect of the [125I]LDL freezing and stor-
age in the presence of 1.4 mol/1 dimethyl sulphoxide
on LDL-receptor activity.
Electron microscopy
To study the effect of freezing and storage in the pres-
ence of dimethyl sulphoxide upon the LDL morphologic
properties, one of the two aliquots of LDL was exam-
ined in the electron microscope within 1 week after iso-
lation, and the second one after freezing with 1.4 mol/1
dimethyl sulphoxide as described in Materials and Meth-
ods, and subsequent storage for 2 years at —70 °C (data
not shown). The particles in both samples appeared to
be relatively uniform in size. In both cases the average
size of particles was 22 ± 2 nm, which was in
Eur J Clin Chem Clin Biochem 1995; 33 (No 2)
78 Sigalov: Cryopreservation and long-term storage of human low density lipoproteins
Tab. 2 Effect of LDL freezing with"i.4 mol/1 dimethyl sulphoxide and subsequent storage at
-70 °C on apolipoprotein B quantitation by immunoprecipitin methodsa.
Method Concentration of apolipoprotein B, g/1
LDL1 LDL2
Radial immunodiffusion
Electroimmunoassay
Immunoturbidimetric assay
freshly
isolated
23.4 ± 0.8
23.8 ± 0.7
23.6 ± 1.0
preserved
23.6 ± 0.6
24.2 ± 1.0
23.5 ± 0.8
control
19.7 ± 0.7
18.4 ±0.8
23.2 ± 0.8
freshly
isolated
13.7 ± 0.5
13.7 ± 0.4
13.8 ± 0.3
preserved
13.4 ± 0.5
13.4 ± 0.4
13.9 ± 0.3
control
11.3 ±0.6
10.4 ±0.3
13.9 ± 0.3
a
 Two LDL preparations (LDL1 and LDL2) were obtained as de-
scribed in Materials and Methods. Aliquots of LDL were as-
sessed for apolipoprotein B content immediately after isolation
("freshly isolated") and after freezing and subsequent storage for
2 years at -70 °C in the presence ("preserved") or in the absence
("control") of 1.4 mol/1 dimethyl sulphoxide. All values are means
± SD from triplicate determinations.
Tab. 3 Comparison of "freshly isolated" and "preserved"
[I251]LDL (freezing with 1.4 mol/1 dimethyl sulphoxide and subse-
quent storage for 7 days at —70 °C) specific binding by human
skin fibroblasts*, internalization and degradation at 37 °C.
Lipoprotein ng of 125I-labelled lipoprotein per mg cell protein
Binding Internalization
Preserved [125I]LDL
10mg/l
20 mg/1
76.9 ±2.1
146.9 ± 2.3
683.4 ± 9.8
1124.8 ±22.1
Degradation
Freshly isolated [125I]LDL
10 mg/1
20 mg/1
75.0 ± 1.2
149.7 ±3.1
679.8 ± 8.3
11 09.5 ±26.2
1026.4 ± 28.5
1734.8 ± 36.3.-_
1013.7 ±25.6
1716.6 ±33.7
a
 Human fibroblasts were incubated for 3 h at 37 °C with the indi-
cated concentrations of radiolabelled lipoproteins. The binding,
internalization and degradation were determined as described in
Materials and Methods and were corrected for non-specific bind-
ing, internalization and degradation in the presence of 20-fold ex-
cess of unlabelled human LDL. All values are means ± SD from
triplicate determinations.
agreement with reported data on particle sizes of such
LDLsubfraction(Sl).
Thus, the LDL freezing in the presence of 1.4 mol/1 di-
methyl sulphoxide and their subsequent storage for up
to 2 years at -70 °C do not lead to an obvious alteration
of morphologic LDL properties.
Discussion
In a majority of research and clinical studies which in-
volved LDL isolation, the researchers have always
stressed the necessity to use only freshly isolated LDL,
due to the rather quick alterations occurring in the LDL
native properties by storage. Thus, for example, to study
various immunochemical LDL properties (32), including
LDL application as a primary standard for apolipopro-
tein B measurements by immunochemical assays (11,
19, 23), to study LDL-receptor activity (33, 34), physi-
cal and chemical (35, 36) as well as other LDL proper-
ties it is usually recommended to conduct the experi-
ments using LDL up to 2-4 weeks after their isolation
and storage at 4 °C in the presence of various preserva-
tives. Taking into consideration the labour- and time-
consuming process of LDL isolation and characteriza-
tion as well as the frequent necessity of using one well-
characterized portion of LDL, for numerous scientific
experiments (for example, in long-term comparative
studies) we conclude that the task of long-term LDL
storage is a topical and important one.
Aggregation, oxidizing degradation, proteolysis and li-
polysis can be major causes for the alterations of native
LDL properties occurring during long-term storage. It
is obvious that conventional freezing can dramatically
decrease the contribution of the latter three processes to
LDL denaturation. Nevertheless, according to our
electrophoretic data, irreversible formation of aggre-
gated LDL particles occurs upon freezing without an
evident apolipoprotein B fragmentation in these particles
in contrast to oxidizing (with Cu2+) LDL degradation
(37), where, as the authors believe, the generated aggre-
gates present LDL particles cross-linked via apolipo-
protein B fragments. The formation of LDL aggregates
Eur J Clin Chem Clin Biochem 1995; 33 (No 2)
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was observed by their intensive vortexing as well (38).
It is very likely that the apparent loss of apolipoprotein
B immunoreactivity we observed after long-term storage
of LDL at 4 °C (for more than 1 month) and similar
losses reported previously (39, 40) after LDL freezing
and subsequent storage at —20 °C can be explained by
LDL aggregation. It should also be noted that such ap-
parent losses of apolipoprotein B immunoreactivity were
observed only by using "gel" techniques to determine
apolipoprotein B: single radial immunodiffusion (39,
40), and single radial immunodiffusion and electroim-
munoassay in the present study. This conclusion is sup-
ported by the known dependence of the "rocket" size
upon the size heterogeneity of albumin and haptoglobin
(monomers or dimers) when analyzing them by
electroimmunoassay (41), as well as by the recently re-
ported data showing the impact of the LDL particles
size upon the divergent values between the results of
apolipoprotein B determination by single radial immu-
nodiffusion and immunonephelometric assay (42). As
we have shown for such LDL samples, where the pres-
ence of aggregates was confirmed by non-denaturing
gradient polyacrylamide gel electrophoresis with subse-
quent imrnunoblotting, the apparent loss of apolipopro-
tein B immunoreactivity (up to 23%) is observed only
when "gel" immunochemical techniques (single radial
immunodiffusion and electroimmunoassay) are used in
contrast to immunoturbidimetric assay.
It is obvious that aggregation of LDL can lead to the
alterations not only in immunochemical, but other
(physico-chemical, ability to bind with B,E-receptors
and etc.) native properties of LDL. The electrophoretic
and other data obtained by us show that the degree of
aggregation of LDL during low-temperature storage is
not dependent as much upon the duration of their storage
as directly upon the freeze-thawing process, and dramat-
ically increases (even up to opalescence of the solution
and visible precipitation) at multi-fold repetition of the
operation. The addition of 1.4 mol/1 dimethyl sulphoxide
prior to freezing of LDL and their subsequent long-term
storage at low temperature prevents such LDL aggrega-
tion and allows them to maintain their native properties.
This conclusion was also confirmed by very recently
published data (12), where the authors used sucrose for
Cryopreservation of LDL. The utilization of bovine se-
rum albumin, HDL, and apolipoprotein A-I, having cer-
tain antiaggregatory effect with regard to LDL, to stabi-
lize LDL (38, 40) is impossible in many fields of LDL
application (for example, by examination of physical
and chemical properties of LDL, by obtaining antibodies
against apolipoprotein B, etc.). Thus, we have concen-
trated our efforts on the search for a relevant "cryopro-
tector", exercising minimal influence upon native LDL
properties and allowing alterations in these properties to
be avoided during the freeze-thawing process. Among
cell cryoprotectors used to preserve such complex bio-
logical structures as cells (13, 14), we have selected two
of the most widely used, i.e. glycerol and dimethyl
sulphoxide. Nevertheless, the results of the preliminary
experiments on the utilization of glycerol as a cryopro-
tector to stabilize LDL were negative, leading us to fur-
ther study the possibility of application of only dimethyl
suphoxide to preserve LDL.
The data obtained show that the addition of 1.4 mol/1
dimethyl sulphoxide directly to the solution of freshly
isolated LDL in its high salt buffer and subsequent
freezing in accordance with the above method allow
LDL to be stored at —70 °C (or preferably in liquid ni-
trogen) for a considerable period (for up to at least 2
years, and perhaps even longer) without any alterations
in their native properties. Moreover, as we also used
highly concentrated LDL samples (10-30 g/1 by pro-
tein), a number of duplicated experiments performed
have shown that in many cases (immunochemical apoli-
poprotein B determination, LDL binding with B,E-re-
ceptors, animal immunization, electrophoretic methods
of analysis, electron microscopy, etc.), when LDL are
used in a highly diluted state, preliminary dialysis of
the "preserved" LDL samples is not necessary. Using
[125I]LDL as an example, we have shown the possibility
of storage of radiolabelled LDL samples, but in this case
the storage time is probably limited by the lifetimes of
the relevant radioisotopes. Our observations also
strongly suggest that the thermostability of LDL in the
presence of 1.4 mol/1 dimethyl sulphoxide is rather
higher (A. B. Sigalov, unpublished data). The absence of
significant differences in the properties of the freshly
isolated LDL and the LDL preparations cryopreserved
according to our methods, as well as the stability of
these properties during long-term storage, prove the
minimal impact of dimethyl sulphoxide upon the struc-
ture and properties of lipoprotein particles, although its
destabilizing effect on the secondary protein structure
was reported (43).
Thus, the data obtained indicate that dimethyl sulph-
oxide can be successfully used as a cryoprotector for
long-term storage of LDL at low temperature as well as
sucrose (12) at least in the applications used. However,
it is quite possible that in any particular applications one
of them will be preferable. The given methods of LDL
Cryopreservation may be quite universal with regard to
other classes of human lipoproteins and at present we
are conducting relevant studies in this direction.
In conclusion we would like to express our hope that
the suggested simple and effective technique of LDL
storage might find wide application in clinical and bio-
medical investigations.
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